LOGIN
Thrombin-based hemostatic agent associated with reduced drain output & transfusion in TKA
March 2015
Thrombin-based hemostatic agent associated with reduced drain output & transfusion in TKA
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Efficacy of intra-articular injection of thrombin-based hemostatic agent in the control of bleeding after primary total knee arthroplasty
Knee Surg Relat Res. 2014 Dec;26(4):236-40Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
100 patients scheduled for total knee arthroplasty were randomized to either receive or not receive intraoperative intraarticular administration of a thrombin-based hemostatic agent. The purpose of this study was to determine the efficacy of the thrombin-based hemostatic agent (Floseal, Baxter) on reducing blood loss following total knee arthroplasty. Drain output, hemoglobin (Hb) and hematocrit l...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.